Maintenance of Potent Cellular and Humoral Immune Responses in Long-Term Hemodialysis Patients after 1273-mRNA SARS-CoV-2 Vaccination

Continuous evaluation of the coronavirus disease 2019 (COVID-19) vaccine effectiveness in hemodialysis (HD) patients is critical in this immunocompromised patient group with higher mortality rates due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The response towards vac...

Descripción completa

Detalles Bibliográficos
Autores principales: Gonzalez-Perez, Maria, Baranda, Jana, Berges-Buxeda, Marcos J., Conde, Patricia, Pérez-Olmeda, Mayte, Lozano-Ojalvo, Daniel, Cámara, Carmen, del Rosario Llópez-Carratalá, Maria, Gonzalez-Parra, Emilio, Portolés, Pilar, Ortiz, Alberto, Portoles, Jose, Ochando, Jordi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10141011/
https://www.ncbi.nlm.nih.gov/pubmed/37111331
http://dx.doi.org/10.3390/ph16040574

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10141011/
https://www.ncbi.nlm.nih.gov/pubmed/37111331
http://dx.doi.org/10.3390/ph16040574

Ejemplares similares